IFG Advisory LLC Grows Stock Position in iShares Biotechnology ETF $IBB

Posted by Latisha Jones on May 30th, 2026

IFG Advisory LLC increased its position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 174.7% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 11,374 shares of the financial services provider’s stock after buying an additional 7,233 shares during the quarter. IFG Advisory LLC’s holdings in iShares Biotechnology ETF were worth $1,920,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in IBB. Cary Street Partners Financial LLC purchased a new stake in iShares Biotechnology ETF in the fourth quarter valued at approximately $29,000. Darwin Wealth Management LLC acquired a new position in iShares Biotechnology ETF during the second quarter worth $25,000. Cornerstone Planning Group LLC acquired a new position in iShares Biotechnology ETF during the fourth quarter worth $35,000. Copia Wealth Management acquired a new position in iShares Biotechnology ETF during the fourth quarter worth $34,000. Finally, Strategic Wealth Advisors LLC acquired a new position in iShares Biotechnology ETF during the fourth quarter worth $35,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ:IBB opened at $172.18 on Friday. The stock’s fifty day moving average is $169.35 and its two-hundred day moving average is $170.34. iShares Biotechnology ETF has a 52 week low of $120.33 and a 52 week high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 20th. Shareholders of record on Tuesday, March 17th were paid a dividend of $0.1218 per share. This represents a $0.49 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date was Tuesday, March 17th.

iShares Biotechnology ETF Company Profile

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.